Lack of antiviral activity of darunavir against SARS-CoV-2
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2020.04.03.20052548: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Experimental Models: Cell Lines Sentences Resources After one passage in Caco-2 cells, viral stocks were stored at –80°C prior to use. Caco-2suggested: NoneAssessment of Cell Viability: To assess the effects of the compounds on Caco–2 cell viability, cell viability was measured in confluent cell layers treated with a range of compound concentrations in absence of virus using the Rotitest Vital (Roth) according to manufacturer’s instructions, as previously described (12). Caco–2suggested…SciScore for 10.1101/2020.04.03.20052548: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Experimental Models: Cell Lines Sentences Resources After one passage in Caco-2 cells, viral stocks were stored at –80°C prior to use. Caco-2suggested: NoneAssessment of Cell Viability: To assess the effects of the compounds on Caco–2 cell viability, cell viability was measured in confluent cell layers treated with a range of compound concentrations in absence of virus using the Rotitest Vital (Roth) according to manufacturer’s instructions, as previously described (12). Caco–2suggested: NoneSoftware and Algorithms Sentences Resources Data were analyzed by a four-parameter curve-fitting from a dose-response curve using GraphPad Prism (version 7.00) to calculate the EC50 (concentration of the compound that inhibited 50% of the infection) based on visual CPE scoring or based on the MTT method. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-